-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MqR3EXeC8Tk+cmLLLMfHyRZt4JPc7r+MkywwDbXlyq/fnL20C5LFfWkiHq1fMwdi LK5HpV6NNC/ASofuMgOHDg== 0001018871-07-000025.txt : 20070510 0001018871-07-000025.hdr.sgml : 20070510 20070510162908 ACCESSION NUMBER: 0001018871-07-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070503 FILED AS OF DATE: 20070510 DATE AS OF CHANGE: 20070510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHTRONICS, INC. CENTRAL INDEX KEY: 0001018871 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 582210668 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CAPITAL OF TEXAS HWY. STREET 2: SUITE B-200 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 512.328.2892 MAIL ADDRESS: STREET 1: 1301 CAPITAL OF TEXAS HWY. STREET 2: SUITE B-200 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHTRONICS SURGICAL SERVICES INC DATE OF NAME CHANGE: 20010613 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHTRONICS INC /GA DATE OF NAME CHANGE: 19980623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SEARLES WILLIAM A CENTRAL INDEX KEY: 0001113921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30406 FILM NUMBER: 07838237 BUSINESS ADDRESS: STREET 1: 1467 LEMAY, SUITE 111 CITY: CARROLLTON STATE: TX ZIP: 75007 MAIL ADDRESS: STREET 1: 1301 CAPITAL OF TX HWY CITY: AUSTIN STATE: TX ZIP: 78746 4 1 searles050307_ex.xml X0202 4 2007-05-03 0 0001018871 HEALTHTRONICS, INC. HTRN 0001113921 SEARLES WILLIAM A 1301 CAPITAL OF TX HWY SUITE 200B AUSTIN TX 78746 1 0 0 0 Option to Purchase Common Stock 7.79 2007-05-03 4 D 0 20000 D 2013-02-26 Common Stock 20000 0 D Option to Purchase Common Stock 7.79 2007-05-03 4 A 0 20000 A 2013-02-26 Common Stock 20000 20000 D Option to Purchase Common Stock 5.69 2007-05-03 4 D 0 20000 D 2014-02-19 Common Stock 20000 0 D Option to Purchase Common Stock 5.69 2007-05-03 4 A 0 20000 A 2014-02-19 Common Stock 20000 20000 D Option to Purchase Common Stock 7.39 2007-05-03 4 D 0 25000 D 2014-12-01 Common Stock 25000 0 D Option to Purchase Common Stock 7.39 2007-05-03 4 A 0 25000 A 2014-12-01 Common Stock 25000 25000 D Option to Purchase Common Stock 7.49 2007-05-03 4 D 0 25000 D 2015-12-01 Common Stock 25000 0 D Option to Purchase Common Stock 7.49 2007-05-03 4 A 0 25000 A 2015-12-01 Common Stock 25000 25000 D Option to Purchase Common Stock 6.70 2007-05-03 4 D 0 50000 D 2016-12-05 Common Stock 50000 0 D Option to Purchase Common Stock 6.70 2007-05-03 4 A 0 50000 A 2016-12-05 Common Stock 50000 50000 D The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the option and the grant of a replacement option. The option was originally granted on February 26, 2003, was fully vested on the date of grant and under the terms of the option, the option was exercisable for a period of 90 days after termination of Mr. Searles' service as a director. On April 2, 2007, the Board of Directors of the Company, effective immediately prior to the termination of Mr. Searles' service as a director, extended the exercisability period from 90 days after such termination to until December 31, 2008. The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the option and the grant of a replacement option. The option was originally granted on February 19, 2004, was fully vested on the date of grant and under the terms of the option, the option was exercisable for a period of 90 days after termination of Mr. Searles' service as a director. On April 2, 2007, the Board of Directors of the Company, effective immediately prior to the termination of Mr. Searles' service as a director, extended the exercisability period from 90 days after such termination to until December 31, 2008. The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the option and the grant of a replacement option. The option was originally granted on December 1, 2004, was fully vested on the date of grant and under the terms of the option, the option was exercisable for a period of 90 days after termination of Mr. Searles' service as a director. On April 2, 2007, the Board of Directors of the Company, effective immediately prior to the termination of Mr. Searles' service as a director, extended the exercisability period from 90 days after such termination to until December 31, 2008. The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the option and the grant of a replacement option. The option was originally granted on December 1, 2005, was fully vested on the date of grant and under the terms of the option, the option was exercisable for a period of 90 days after termination of Mr. Searles' service as a director. On April 2, 2007, the Board of Directors of the Company, effective immediately prior to the termination of Mr. Searles' service as a director, extended the exercisability period from 90 days after such termination to until December 31, 2008. The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the option and the grant of a replacement option. The option was originally granted on December 5, 2006, with 25,000 shares vesting immediately and 25,000 shares vesting on each of the first 3 anniversaries of the date of grant. Under the terms of the option, the option was exercisable for a period of 90 days after termination of Mr. Searles' service as a director. On April 2, 2007, the Board of Directors of the Company, effective immediately prior to the termination of Mr. Searles' service as a director, (i) extended the exercisability period from 90 days after such termination to until December 31, 2008 and (ii) provided that an additional 25,000 shares would vest immediately. The remaining 50,000 shares covered by the option were not vested at the time of the termination of Mr. Searles' service as a director and therefore automatically expired at such time in accordance with the terms of the Company's 2004 Equity Incentive Plan and the option agreement. /s/ William Searles 2007-05-10 -----END PRIVACY-ENHANCED MESSAGE-----